EP0975610A4 - Composes pharmaceutiques a base de tripeptides et de tetrapeptides - Google Patents

Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Info

Publication number
EP0975610A4
EP0975610A4 EP98907625A EP98907625A EP0975610A4 EP 0975610 A4 EP0975610 A4 EP 0975610A4 EP 98907625 A EP98907625 A EP 98907625A EP 98907625 A EP98907625 A EP 98907625A EP 0975610 A4 EP0975610 A4 EP 0975610A4
Authority
EP
European Patent Office
Prior art keywords
tetrapeptide
tripeptide
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98907625A
Other languages
German (de)
English (en)
Other versions
EP0975610A1 (fr
Inventor
Bryan H Norman
Chuan Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii
Wayne State University
Eli Lilly and Co
Original Assignee
University of Hawaii
Wayne State University
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii, Wayne State University, Eli Lilly and Co filed Critical University of Hawaii
Publication of EP0975610A1 publication Critical patent/EP0975610A1/fr
Publication of EP0975610A4 publication Critical patent/EP0975610A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP98907625A 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides Withdrawn EP0975610A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3911597P 1997-02-26 1997-02-26
US39115P 1997-02-26
PCT/US1998/003666 WO1998038178A1 (fr) 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Publications (2)

Publication Number Publication Date
EP0975610A1 EP0975610A1 (fr) 2000-02-02
EP0975610A4 true EP0975610A4 (fr) 2000-05-17

Family

ID=21903772

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98907625A Withdrawn EP0975610A4 (fr) 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Country Status (5)

Country Link
EP (1) EP0975610A4 (fr)
JP (1) JP2001513775A (fr)
AU (1) AU6338698A (fr)
CA (1) CA2281107A1 (fr)
WO (1) WO1998038178A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008812A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Procede de preparation de composes pharmaceutiques
EP1229934B1 (fr) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040184A1 (fr) * 1995-03-07 1996-12-19 University Of Hawaii Nouvelles cryptophycines obtenues par synthese
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1997023211A1 (fr) * 1995-12-22 1997-07-03 Eli Lilly And Company Composes pharmaceutiques
WO1998008506A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques
WO1998008505A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194605A (en) * 1989-12-08 1993-03-16 Merck & Co., Inc. Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
US5254682A (en) * 1989-12-08 1993-10-19 Merck & Co., Inc. Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040184A1 (fr) * 1995-03-07 1996-12-19 University Of Hawaii Nouvelles cryptophycines obtenues par synthese
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1997023211A1 (fr) * 1995-12-22 1997-07-03 Eli Lilly And Company Composes pharmaceutiques
WO1998008506A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques
WO1998008505A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOISO, YUKIKO ET AL: "Effects of arenastatin A and its synthetic analogs on microtubule assembly", CHEM.-BIOL. INTERACT. (1996), 102(3), 183-191, 1996, XP000872569 *
See also references of WO9838178A1 *

Also Published As

Publication number Publication date
JP2001513775A (ja) 2001-09-04
WO1998038178A1 (fr) 1998-09-03
CA2281107A1 (fr) 1998-09-03
EP0975610A1 (fr) 2000-02-02
AU6338698A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
EP1010705A4 (fr) Derives tetrapeptides cycliques et leur utilisation medicinale
IL128529A0 (en) Anti-inflammatory peptides and uses thereof
HUP9902751A3 (en) Oral peptide pharmaceutical products
EP1064022A4 (fr) Peptides de liaison de hla et leurs applications
IL125361A0 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HRP970308A2 (en) Peptide derivatives
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
GB9806806D0 (en) Peptides and uses thereof
HRP970099B1 (en) Peptide derivatives
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB9504761D0 (en) Amphiphilic peptide and analogs thereof
IL125908A (en) Peptides and pharmaceutical compositions comprising same
GB9718110D0 (en) Peptides
GB9624562D0 (en) Peptide derivatives
IL125262A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
GB9714276D0 (en) Peptides and related compounds
GB9700154D0 (en) Peptides
EP0975610A4 (fr) Composes pharmaceutiques a base de tripeptides et de tetrapeptides
EP0935608A4 (fr) Peptides cytotoxiques
EP0996457A4 (fr) Peptides liberateurs de f.s.h.
IL116976A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
ZA988023B (en) Cyclic tetrapeptide derivatives and pharmaceutical use thereof
IL123429A0 (en) Peptides and pharmaceutical compositions comprising same
ZA200007512B (en) Peptide antangiogenic drugs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990819

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990810;LT PAYMENT 19990819;LV PAYMENT 19990819;RO PAYMENT 19990819;SI PAYMENT 19990819

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 273/00 A, 7C 07D 413/06 B, 7A 61K 31/395 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000330

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20011115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020326